Physician profile
Shiv Kumar Agarwal
NPI 1306147301
$3,023.05
in general payments reported to CMS, 2019-2025
23 companies · $653 in 2025
The $653 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $21.33 · 2022: $399 · 2023: $723 · 2024: $986 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,362.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $528.46 | 2019-2024 | Avvigo Guidance System |
| Penumbra, INC. | $470.72 | 2024-2025 | Indigo System |
| Pfizer INC. | $294.03 | 2022-2025 | |
| Abiomed | $220.69 | 2023-2025 | Impella |
| Shockwave Medical, INC | $218.25 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $190.52 | 2022-2024 | |
| Angiodynamics, INC. | $172.06 | 2024 | Alphavac |
| Cvrx, INC. | $131.63 | 2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $126.14 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Abbott Laboratories | $119.89 | 2024 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.95 | 2020-2025 | Lifevest |
| Biotronik INC. | $71.09 | 2019 | |
| Cardiva Medical, INC. | $69.67 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.26 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $51.19 | 2023-2025 | Verquvo, Winrevair |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $42.28 | 2022-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $39.66 | 2024-2025 | Airsupra |
| Chiesi USA, INC. | $34.16 | 2024-2025 | Kengreal |
| Vital Connect, INC | $29.16 | 2024 | Vitalpatch Rtm |
| Janssen Pharmaceuticals, INC | $21.69 | 2023 | Xarelto |
| Inari Medical, INC. | $15.55 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $12.73 | 2023 | Lutonix Drug Coated Balloon |
| Medtronic Vascular, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiv Kumar Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.